Home » IP Update

IP Update

Nov 11, 2010
Premium

Title: Compositions and Methods for Inhibiting Expression of a Target Gene

Patent Number: 7,829,693

Filed: March 7, 2003

Lead Inventor: Roland Kreutzer, Alnylam Pharmaceuticals

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

This Week in PNAS

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

'Lifestyle Zone'

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

What's Popular?

In Gene Silencing/Gene Editing

  1. Bio-Rad Laboratories Aims to Create Genome Editing Tools Pipeline, Starting With ddPCR

    Premium

  2. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR Library

  3. UC Riverside Team Wins $14.9M DARPA Grant for Genetic Mosquito Control Research

  4. Christiana Care, NovellusDx Ink Licensing Deal for Gene-Editing Tech

  5. Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.